Host Response to Infection and Treatment in Filarial Diseases
Recruiting
Observational Study
Filariasis
Helminthiasis
Parasitic Infection
Mansonelliasis
Onchocerciasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate and treat patients with filarial infections to explore in depth the immunology of the disease, including susceptibility to infection, disease development, and response to treatment. Filarial infections are caused by parasitic worms. The immature worm (larva) is transmitted to a person through a mosquito bite and grows in the human body to 2 to 4 inches in length. Although …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* INCLUSION CRITERIA:
Age 3-100 years.
Access to a primary medical care provider outside of the NIH.
Ability to give informed consent.
Clinical evidence suggestive of a filarial infection
EXCLUSION CRITERIA:
Although pregnant or nursing women can be enrolled, they will be excluded from receivi…
Contacts